Smo Md GmbH

At Smo Md GmbH in Magdeburg, cardiovascular research focuses on heart and vascular disease, including high-risk patients, hypertension, and elevated cholesterol. These trials are designed to assess new ways to lower major cardiovascular events and improve long-term prevention.

• Studies in atherosclerotic cardiovascular disease, high cardiovascular risk, and related conditions
• Research on hypertension and heart, stroke, and vascular complications
• Trials evaluating treatments for LDL cholesterol, Lp(a), and broader risk reduction

Overall, this area aims to improve cardiovascular prevention and help reduce serious events such as heart attack and stroke.

Research in immune-mediated disease at this site centers on asthma and related inflammatory conditions. The studies are mainly exploring new therapies that may better control symptoms, reduce flare-ups, and support people with more difficult-to-treat disease.

• Trials in severe asthma, eosinophilic asthma, and inadequately controlled asthma
• Investigation of treatments for COPD and airway inflammation
• Work on improving lung function and lowering exacerbation rates

This therapeutic area reflects a strong focus on respiratory inflammation and on finding more effective options for chronic airway disease.

The musculoskeletal program includes studies in knee osteoarthritis, with attention to pain relief and everyday function. These trials are intended to evaluate whether new treatments can better ease discomfort and improve quality of life for people living with joint disease.

• Clinical research in knee osteoarthritis pain
• Evaluation of therapies aimed at reducing joint pain
• Focus on improving mobility and patient-reported outcomes

This work supports better management of degenerative joint disease through more targeted pain-control strategies.

Metabolic research at Zentrum für klinische Studien covers obesity, overweight, type 2 diabetes, and lipid disorders such as hypertriglyceridemia. The trials are testing new approaches to weight management, blood sugar control, and reduction of harmful blood fats.

• Studies in obesity and overweight, including people with type 2 diabetes
• Research on hypertriglyceridemia and lipoprotein disorders
• Trials aimed at improving body weight, glucose control, and metabolic risk

These studies are designed to support better long-term care for metabolic disease and its cardiovascular consequences.

Respiratory trials at the site examine asthma and chronic obstructive pulmonary disease, with an emphasis on symptom control, breathing function, and prevention of worsening disease. The research includes both inhaled treatments and newer targeted therapies.

• Studies in asthma, including severe and uncontrolled asthma
• Research in COPD to reduce exacerbations and improve respiratory health
• Evaluation of therapies that may improve airway inflammation and lung function

Overall, this field is centered on finding more effective ways to manage chronic respiratory disease.

The infectious disease portfolio includes studies in influenza and herpes zoster. These trials are focused on evaluating vaccines that may improve protection, strengthen immune response, and reduce the burden of viral illness in adults.

• Vaccine research for influenza
• Studies on prevention of herpes zoster
• Assessment of immune protection and longer-term effectiveness

This area reflects ongoing efforts to improve viral disease prevention through better immunization strategies.